To Top

Community

Sarah Haywood

Sarah has been leading MedCity since its launch in April 2014. Having gained a degree in biology from the University of Oxford, Sarah started her career in the NHS, before joining Novartis Pharmaceuticals Research as the Head of Operations for a neuroscience drug discovery unit. Sarah then joined the civil service, where she worked on a range of policy issues including leading the Department for Trade and Investment Bioscience Unit, before joining London & Partners at the beginning of 2014, from where she worked with Dr Eliot Forster, to establish MedCity.

Contribution
Innovation

A Culture of Innovation in Southeast England

Sarah Haywood, CEO, MedCity

PTV-M06-17-BIO-007